02020R1737 — EN — 23.11.2020 — 000.002

This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document

►B COMMISSION DELEGATED REGULATION (EU) 2020/1737 of 14 July 2020 amending Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005 as regards the inclusion of certain drug precursors in the list of scheduled substances (Text with EEA relevance) (OJ L 392 23.11.2020, p. 1)





Corrected by:









▼B

COMMISSION DELEGATED REGULATION (EU) 2020/1737

of 14 July 2020

amending Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005 as regards the inclusion of certain drug precursors in the list of scheduled substances

(Text with EEA relevance)







Article 1

Amendments to Regulation (EC) No 273/2004

Annexes I and II to Regulation (EC) No 273/2004 are amended in accordance with Annex I to this Regulation.

Article 2

Amendments to Regulation (EC) No 111/2005

The Annex to Regulation (EC) No 111/2005 is amended in accordance with Annex II to this Regulation.

Article 3

Entry into force and application

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Point (1)(b) and point (2) of Annex I and point (2)(b) of Annex II shall apply from 13 January 2021.

This Regulation shall be binding in its entirety and directly applicable in all Member States.









ANNEX I

Annexes I and II to Regulation (EC) No 273/2004 are amended as follows:

(1) Annex I is amended as follows: (a) the table ‘CATEGORY 1’ is amended as follows: (i) the entry for Alpha-phenylacetoacetonitrile is replaced by the following:



Substance CN designation (if different) CN Code CAS No ‘Alpha-phenylacetoacetonitrile (APAAN) 2926 40 00 4468-48-8’ (ii) in the entry for (1R,2S)-(-)-chloroephedrine, the CN code ‘2939 99 00 ’ is replaced by ‘2939 79 90 ’; (iii) in the entry for (1S,2R)-(+)-chloroephedrine, the CN code ‘2939 99 00 ’ is replaced by ‘2939 79 90 ’; (iv) in the entry for (1S,2S)-(+)-chloropseudoephedrine, the CN code ‘2939 99 00 ’ is replaced by ‘2939 79 90 ’; (v) in the entry for (1R,2R)-(-)-chloropseudoephedrine, the CN code ‘2939 99 00 ’ is replaced by ‘2939 79 90 ’; (vi) the following entries are inserted in the appropriate place sequentially according to the CN Code:



Substance CN designation (if different) CN Code CAS No ‘Methyl 3-(1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylate (PMK methyl glycidate) 2932 99 00 13605-48-6 3-(1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylic acid (PMK glycidic acid) 2932 99 00 2167189-50-4 Alpha-phenylacetoacetamide (APAA) 2924 29 70 4433-77-6 Methyl 2-methyl-3-phenyloxirane-2-carboxylate (BMK methyl glycidate) 2918 99 90 80532-66-7 2-methyl-3-phenyloxirane-2-carboxylic acid (BMK glycidic acid) 2918 99 90 25547-51-7 Methyl alpha-phenylacetoacetate (MAPA) 2918 30 00 16648-44-5’ (b) in the table ‘SUBCATEGORY 2A’, the following entry is inserted in the appropriate place sequentially according to the CN Code:



Substance CN designation (if different) CN Code CAS No. ‘Red phosphorus 2804 70 00 7723-14-0’ ▼C1 (c) in the entry for Anthranilic acid in the table ‘SUBCATEGORY 2B’, the CN code ‘2922 43 00 ’ is replaced by ‘2922 43 00 ’; ▼B (d) in the entry for Sulphuric acid in the table ‘CATEGORY 3’, the CN code ‘2807 00 10 ’ is replaced by ‘2807 00 00 ’;

(2) in the table in Annex II, the following entry is added:



Substance Threshold ‘Red phosphorus 0,1 kg’









ANNEX II

The Annex to Regulation (EC) No 111/2005 is amended as follows:

(1) the table ‘CATEGORY 1’ is amended as follows: (a) the entry for Alpha-phenylacetoacetonitrile is replaced by the following:



Substance CN designation (if different) CN Code CAS No ‘Alpha-phenylacetoacetonitrile (APAAN) 2926 40 00 4468-48-8’ (b) in the entry for (1R,2S)-(-)-chloroephedrine, the CN code ‘2939 99 00 ’ is replaced by ‘2939 79 90 ’; (c) in the entry for (1S,2R)-(+)-chloroephedrine, the CN code ‘2939 99 00 ’ is replaced by ‘2939 79 90 ’; (d) in the entry for (1S,2S)-(+)-chloropseudoephedrine, the CN code ‘2939 99 00 ’ is replaced by ‘2939 79 90 ’; (e) in the entry for (1R,2R)-(-)-chloropseudoephedrine, the CN code ‘2939 99 00 ’ is replaced by ‘2939 79 90 ’; (f) the following entries are inserted in the appropriate place sequentially according to the CN Code:



Substance CN designation (if different) CN Code CAS No ‘Methyl 3-(1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylate (PMK methyl glycidate) 2932 99 00 13605-48-6 3-(1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylic acid (PMK glycidic acid) 2932 99 00 2167189-50-4 Alpha-phenylacetoacetamide (APAA) 2924 29 70 4433-77-6 Methyl 2-methyl-3-phenyloxirane-2-carboxylate (BMK methyl glycidate) 2918 99 90 80532-66-7 2-methyl-3-phenyloxirane-2-carboxylic acid (BMK glycidic acid) 2918 99 90 25547-51-7 Methyl alpha-phenylacetoacetate (MAPA) 2918 30 00 16648-44-5’

▼C1

(2) the table ‘Category 2’ is amended as follows: (a) in the entry for Anthranilic acid in, the CN code ‘2922 43 00 ’ is replaced by ‘2922 43 00 ’; ▼B (b) the following entry is inserted in the appropriate place sequentially according to the CN Code:



Substance CN designation (if different) CN Code CAS No. ‘Red phosphorus 2804 70 00 7723-14-0’

(3) in the entry for Sulphuric acid in the table ‘Category 3’, the CN code ‘2807 00 10 ’ is replaced by ‘2807 00 00 ’;